Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Arq Bras Oftalmol. 2023 May-Jun;86(3):223-231. doi: 10.5935/0004-2749.20230042.
To compare viscotrabeculotomy with anterior chamber irrigation to Ahmed glaucoma valve implantation for secondary glaucoma following silicone oil removal.
A prospective study was conducted on 43 vitrectomized pseudophakic eyes with persistent glaucoma after silicone oil removal. Patients were randomized to either viscotrabeculotomy with anterior chamber irrigation or Ahmed glaucoma valve implantation. All patients were examined on day 1, week 1, and months 1, 3, 6, 9, 12, 18, and 24 postoperatively. Postoperative complications were noted. Success was defined as an intraocular pressure between 6 and 20 mmHg and with an intraocular pressure reduction of >30% compared with the preoperative intraocular pressure.
There were 22 eyes in the viscotrabeculotomy with anterior chamber irrigation and 21 eyes in the Ahmed glaucoma valve implantation group. The mean preoperative and postoperative intraocular pressure in the viscotrabeculotomy with anterior chamber irrigation and Ahmed glaucoma valve implantation groups were 35.5 ± 2.6 mmHg and 35.5 ± 2.4 mmHg and 16.9 ± 0.7 mmHg and 17.9 ± 0.9 mmHg respectively (p˂0.0001). There was a statistically significant intraocular pressure reduction at all follow-up time points compared to preoperative values (p˂0.0001) in both groups. The unqualified success rate in the viscotrabeculotomy with anterior chamber irrigation and Ahmed glaucoma valve implantation groups were 72.73% and 61.9%, respectively. A minimal self-limited hyphema was the most common complication.
Both viscotrabeculotomy with anterior chamber irrigation and Ahmed glaucoma valve implantation are effective in lowering the intraocular pressure in glaucoma after silicone oil removal with viscotrabeculotomy with anterior chamber irrigation providing greater reduction, higher success rates, and minimal complications.
比较硅油取出后继发性青光眼行房水引流小梁切开术与 Ahmed 青光眼阀植入术的疗效。
前瞻性研究了 43 例硅油取出后继发性青光眼的玻璃体切割术后无晶状体眼。患者随机分为房水引流小梁切开术组或 Ahmed 青光眼阀植入术组。所有患者术后第 1、1 周、1、3、6、9、12、18 和 24 个月进行检查。记录术后并发症。成功定义为眼压 6~20mmHg,与术前眼压相比,眼压降低>30%。
房水引流小梁切开术组 22 例,Ahmed 青光眼阀植入术组 21 例。房水引流小梁切开术组和 Ahmed 青光眼阀植入术组术前和术后平均眼压分别为 35.5±2.6mmHg 和 35.5±2.4mmHg,16.9±0.7mmHg 和 17.9±0.9mmHg(p<0.0001)。两组在所有随访时间点的眼压均较术前显著降低(p<0.0001)。房水引流小梁切开术组和 Ahmed 青光眼阀植入术组的不合格成功率分别为 72.73%和 61.9%。最常见的并发症是轻微自限性前房积血。
硅油取出后继发性青光眼行房水引流小梁切开术与 Ahmed 青光眼阀植入术均可有效降低眼压,房水引流小梁切开术眼压降低更明显,成功率更高,并发症更少。